Acceptable liver transplant outcomes seen after ICI therapy for liver cancer
For patients with hepatocellular carcinoma (HCC), immune checkpoint inhibitor (ICI) use prior to liver transplant (LT) does not worsen outcomes, according to research published online July 10 in the Journal of Hepatology.
Aug 19, 2024
0
0